General Infectious Disease News Articles

Infectious Dis.

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kumar A – This article reviews principles in the rational use of antibiotics in sepsis and septic shock and presents evidence–based recommendations for optimal antibiotic therapy. The duration of antibiotic therapy typically is limited to 7 to 10 days; longer duration is considered if response is slow, if there is inadequate surgical source control, or in the case of immunologic deficiencies. Antimicrobial therapy should be stopped if infection is not considered the etiologic factor for a shock state.

Related Articles

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
BMC Infectious Diseases, 10/20/09    Relevance Score: 67%

Empirical Antimicrobial Therapy for Bloodstream Infection Due to Methicillin-Resistant Staphylococcus aureus: No Better than a Coin Toss
Infection Control and Hospital Epidemiology, 10/14/09    Relevance Score: 67%

Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy
Journal of Clinical Pharmacy and Therapeutics, 11/04/09    Relevance Score: 66%

Topical Antimicrobial Therapy for Treating Chronic Wounds
Clinical Infectious Diseases, 10/29/09    Relevance Score: 66%

Antimicrobial Susceptibility of Bacteria Isolated from Urine Samples Obtained from Nursing Home Residents
Infection Control and Hospital Epidemiology, 10/08/09    Relevance Score: 66%

Today in Antimicrobials...keeping you current

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)
Diagnostic Microbiology and Infectious Disease, 11/24/09

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008
Diagnostic Microbiology and Infectious Disease, 11/24/09

Linezolid surveillance program results for 2008 (LEADER Program for 2008)
Diagnostic Microbiology and Infectious Disease, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address